Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Chapin

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-AnalysisJeffrey M Ryckman, Toms V Thomas, Ming Wang, et al.
European Urology|March 4, 2011
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombusNicholas G Cost, Scott E Delacroix, Joshua P Sleeper, et al.
BJU International|April 14, 2023
Definitive local therapy for T4 prostate cancer associated with improved local control and survivalLauren M Andring, Ibrahim Abu-Gheida, Tharakeswara Bathala, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
European Urology|July 6, 2023
Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
European Urology|December 6, 2020
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional TherapiesWeranja Ranasinghe, Daniel D Shapiro, Hyunsoo Hwang, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-AnalysisJeffrey M Ryckman, Toms V Thomas, Ming Wang, et al.
European Urology|March 4, 2011
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombusNicholas G Cost, Scott E Delacroix, Joshua P Sleeper, et al.
BJU International|April 14, 2023
Definitive local therapy for T4 prostate cancer associated with improved local control and survivalLauren M Andring, Ibrahim Abu-Gheida, Tharakeswara Bathala, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
European Urology|July 6, 2023
Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
European Urology|December 6, 2020
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional TherapiesWeranja Ranasinghe, Daniel D Shapiro, Hyunsoo Hwang, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
Pageof 12